• to reduce the risk of major cardiovascular (coronary heart and blood vessel) problems in Older people with type two diabetes and cardiovascular diseaseIn October 2024, Novo Nordisk released a analyze on scientific journal Nature a few novel glucose-sensitive insulin NNC2215 which will lessen the risk of hypoglycemia in animal styles.[67]are sch